Novel Biologics
Designed by Evolution
Discovered by AI
Life finds a way
Evolution’s uncompromising ‘adapt or die’ mantra has birthed some of our most impactful medicines. Consider penicillin, born from Alexander Fleming’s serendipitous antibiotic discovery, now a cornerstone of modern medicine, which added a decade to all of our lives.
AMPLY revitalizes this organic approach, infusing it with AI’s power. Our technology digitizes life’s diversity, using next-gen sequencing for drug discovery—a billion potential solutions on a billion virtual petri dishes. These digital finds are bio-printed into tangible molecules for real-world testing. Our discoveries have been trialled in top hospital labs, pitted against real diseases.
Latest News
AMPLY Discovery wins spot on Techstars Chicago
We are thrilled to share that AMPLY Discovery was selected as one of 12 “exceptional AI startups”, to participate in the Techstars Chicago, powered by
Ben Thomas joins BioTech Nation podcast to discuss how AMPLY Discovery uses AI to speed up the process of finding new effective ways to kill disease threats.
Dr Ben Thomas recently appeared on US podcast “BioTech Nation” with Moira Gunn to describe how the AMPLY Discovery technology uses AI to speed up
Belfast-based AMPLY raises £900k to tackle drug-resistant pathogens with AI
Belfast-based startup AMPLY has raised £900,000 in a joint equity and grant funding round to develop new products that tackle global disease threats from multi-drug